ABTB3 encodes a conserved ankyrin repeat- and BTB/POZ domain-containing protein, also known as BTBD11. The best characterized functional evidence comes from the mouse ortholog Btbd11, which is enriched at glutamatergic postsynaptic densities in cortical and hippocampal inhibitory interneurons. Btbd11 contains a conserved C-terminal PDZ-binding motif that binds PSD-95 (DLG4), promotes PSD-95 stabilization at glutamatergic synapses, and supports excitatory synaptic input onto parvalbumin-positive interneurons. Human ABTB3 is predicted to share this synaptic scaffold/stabilizer role by orthology, but direct human functional assays and CUL3 substrate-adaptor activity have not been established.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0016020 membrane | IEA GO_REF:0000044 | KEEP AS NON CORE | Summary: UniProt maps ABTB3 to membrane based on its subcellular-location record and predicted single-pass membrane association. This broad location is compatible with synaptic localization but is less informative than the orthology-supported glutamatergic synapse term. Reason: Retain as a broad, source-supported cellular-component annotation, but do not treat it as the defining localization. The more functionally informative location is glutamatergic synapse, supported by the mouse Btbd11 paper and transferred to human by orthology. Supporting Evidence: UniProt:A6QL63 SUBCELLULAR LOCATION: Membrane PMID:37261953 These data indicate that Btbd11 is localized at glutamatergic synapses. |
| GO:0046982 protein heterodimerization activity | IEA GO_REF:0000002 | MARK AS OVER ANNOTATED | Summary: This is an InterPro2GO inference from the histone-fold superfamily signature. ABTB3/Btbd11 has experimentally supported protein interactions, most clearly PDZ-mediated binding to PSD-95, but the available gene-specific evidence does not establish a physiologic heterodimerization activity as the molecular function. Reason: The histone-fold architecture may support protein-protein interaction potential, but this broad InterPro transfer is less informative than the directly supported PDZ domain binding annotation. The 2023 Btbd11 study maps the PSD-95 interaction to a C-terminal PDZ-binding motif, not to a demonstrated histone-fold heterodimerization mechanism. Supporting Evidence: UniProt:A6QL63 InterPro; IPR009072; Histone-fold. PMID:37261953 Btbd11 contains a PDZ binding motif that interacts with PDZ1,2 of Psd-95 file:human/ABTB3/ABTB3-deep-research-manual.md InterPro2GO inference from the histone-fold signature rather than a demonstrated physiologic heterodimerization function. The experimentally supported interaction mechanism is PDZ-motif-mediated binding to Psd-95. |
| GO:0030165 PDZ domain binding | IEA GO_REF:0000107 | ACCEPT | Summary: Orthology-transferred annotation from mouse Btbd11. The source study directly supports PDZ-domain binding: the conserved C-terminal PDZ-binding motif is required for interaction with Psd-95/DLG4 PDZ1,2. Reason: This is the best-supported molecular function for ABTB3/Btbd11. The cited mouse paper demonstrates PDZ-motif-dependent interaction with Psd-95 by yeast two-hybrid and GST pulldown assays, and notes conservation of the C-terminal region between species, making orthology transfer to human ABTB3 appropriate. Supporting Evidence: PMID:37261953 The C-terminal region of Btbd11 is highly conserved between species PMID:37261953 Btbd11 could pull down Psd-95-mCherry but only when the PBM was present file:human/ABTB3/ABTB3-deep-research-manual.md `GO:0030165 PDZ domain binding`, because the source mouse study directly maps Psd-95 binding to the Btbd11 C-terminal PDZ-binding motif and the region is conserved. |
| GO:0098978 glutamatergic synapse | IEA GO_REF:0000107 | ACCEPT | Summary: Orthology-transferred annotation from mouse Btbd11. The mouse paper identifies Btbd11 as an inhibitory interneuron postsynaptic-density protein that colocalizes with Psd-95 and is enriched at glutamatergic synapses. Reason: The source evidence directly demonstrates localization at glutamatergic synapses by endogenous labeling, immunofluorescence, and PSD fraction enrichment. This is the most informative cellular-component annotation for ABTB3/Btbd11. Supporting Evidence: PMID:37261953 identifying Btbd11 as an inhibitory interneuron-specific, synapse-enriched protein PMID:37261953 These data indicate that Btbd11 is localized at glutamatergic synapses. file:human/ABTB3/ABTB3-deep-research-manual.md `GO:0098978 glutamatergic synapse`, because Btbd11 colocalizes with Psd-95, not gephyrin, and is enriched in PSD fractions. |
| GO:0005654 nucleoplasm | IDA GO_REF:0000052 | KEEP AS NON CORE | Summary: HPA immunofluorescence supports a nucleoplasm localization signal in surveyed human cells. This does not match the main synaptic biology supported by the mouse ortholog, but it can be retained as a non-core high-throughput localization observation. Reason: Keep as source-specific experimental localization, but do not use it to define the core function of ABTB3. The primary functional evidence points to a glutamatergic synapse role; there is no current mechanistic evidence that a nucleoplasmic ABTB3 pool mediates the core synaptic function. Supporting Evidence: GO_REF:0000052 Gene Ontology annotation based on curation of immunofluorescence data |
| GO:0050821 protein stabilization | ISO PMID:37261953 Btbd11 supports cell-type-specific synaptic function | NEW | Summary: Proposed NEW human annotation by orthology to mouse Btbd11. The source paper shows that Btbd11 promotes Psd-95 stabilization at glutamatergic synapses and that Btbd11 knockout reduces Psd-95 puncta size in parvalbumin-positive interneurons. Reason: This process term captures the experimentally supported synaptic stabilizer role. It is already listed in the human UniProt record as an Ensembl-transferred process annotation, but it was not present in the fetched GOA set; adding it keeps the review aligned with the strongest orthology-supported biology. Supporting Evidence: PMID:37261953 Exogenous expression of Btbd11 stabilizes Psd-95 at glutamatergic synapses PMID:37261953 Psd-95-mCherry FRAP was slower in the presence of overexpressed Btbd11 file:human/ABTB3/ABTB3-deep-research-manual.md `GO:0050821 protein stabilization`, for Btbd11-mediated stabilization of Psd-95 at glutamatergic synapses. |
| GO:0035249 synaptic transmission, glutamatergic | ISO PMID:37261953 Btbd11 supports cell-type-specific synaptic function | NEW | Summary: Proposed NEW human annotation by orthology to mouse Btbd11. Mouse interneuron-specific Btbd11 knockout decreases glutamatergic signaling onto parvalbumin-positive interneurons and alters circuit activity. Reason: This BP term is appropriate as a non-catalytic synaptic-process annotation supported by direct mouse ortholog experiments. It should be kept distinct from the higher-level exploration behavior phenotype, which is downstream and not recommended as a core annotation. Supporting Evidence: PMID:37261953 Knockout of Btbd11 decreased glutamatergic signaling onto parvalbumin-positive interneurons. PMID:37261953 we observed a dramatic decrease in the frequency of mEPSCs file:human/ABTB3/ABTB3-deep-research-manual.md `GO:0035249 synaptic transmission, glutamatergic`, for the decreased glutamatergic signaling in PV interneurons after mouse Btbd11 knockout. |
Loading supporting content…
Download this section (compressed HTML)Q: Does human ABTB3 physically bind DLG4/PSD-95 through the same conserved C-terminal PDZ-binding motif demonstrated for mouse Btbd11?
Q: Does ABTB3 bind CUL3 or any CRL3 substrate in human neurons, or is the PN Cul3 substrate-receptor projection only a domain-architecture hypothesis?
Q: Are the UniProt isoforms functionally different with respect to the C-terminal PDZ-binding motif, synaptic localization, or predicted membrane association?
Q: Do the BTB-domain yeast two-hybrid hits Ataxin1 and Ataxin-1-like represent physiologic ABTB3/Btbd11 interactors in neurons?
Experiment: Test human ABTB3 interaction with DLG4/PSD-95 PDZ domains using yeast two-hybrid or pulldown assays with full-length and PBM-deleted isoforms.
Hypothesis: Human ABTB3 uses a conserved C-terminal PDZ-binding motif to bind DLG4/PSD-95.
Experiment: Express tagged human ABTB3 in human iPSC-derived inhibitory interneurons and quantify localization with PSD-95, gephyrin, and glutamatergic synapse markers.
Hypothesis: Human ABTB3 localizes preferentially to glutamatergic postsynaptic densities rather than inhibitory synapses or nucleoplasm.
Experiment: Perform ABTB3-CUL3 co-immunoprecipitation and ubiquitination/substrate discovery assays in neuronal cells.
Hypothesis: If ABTB3 is a true CRL3 substrate receptor, it should form a CUL3 complex and show substrate-linked ubiquitination activity; absence of these results would argue against propagating the PN Cul3-adaptor term.
Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)